Literature DB >> 20719088

Combined application of neutrophin-3 gene and neural stem cells is ameliorative to delay of denervated skeletal muscular atrophy after tibial nerve transection in rats.

Sen Lin1, Jianguang Xu, Shaonan Hu, Lei Xu, Changqing Zhang, Yang Wang, Yudong Gu.   

Abstract

Examination of the therapeutic efficacy of neural stem cells (NSCs) has recently become the focus of much investigation. In this study we present an insight of the effects of combined application with neurotrophin-3 (NT-3) and NSCs that derived from rat embryo spinal cord on delaying denervated skeletal muscular atrophy after tibial nerve was severed. NT-3 gene was amplified by PCR and subcloned into lentiviral vector pWPXL-MOD to construct a lentiviral expression vector pWPXL-MOD-NT-3. A positive clone expressing NT-3 (named NSCs-NT-3) was obtained and used for differentiation in vitro and transplantation. Sixty adult rats, whose tibial nerves were sectioned, were divided into two groups: one grafted with NSCs-NT-3 (experimental group, n = 30) and the other with NSCs transfected by pWPXL-MOD (control group, n = 30). The cell survival and differentiation, NT-3 gene expression, and effect of delaying denervated skeletal muscular atrophy were examined through immunohistostaining, RT-PCR, Western blot, electrophysiological analysis, and mean cross-sectional area (CSA) of gastrocnemius, respectively. The results show that the NT-3 gene, which is comprised of 777 bp, was cloned and significantly different expression were detected between NSCs and NSCs-NT-3 in vitro. Quantitative analysis of the choline acetyltransferase (ChAT) immunopositive cells revealed a significant increase in experimental group compared to the control group 4 weeks after implantation (p < 0.01). Twelve weeks after transplantation, the ChAT immunopositive cells were detected near the engrafted region only in experimental group. Furthermore, the effect in delaying denervated skeletal muscular atrophy is indicated in the EMG examination and mean CSA of gastrocnemius. These findings suggest that the neural stem cells expressing NT-3 endogenously would be a better graft candidate for the delay of denervated skeletal muscular atrophy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719088     DOI: 10.3727/096368910X524773

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  3 in total

1.  Effects of exogenous neurotrophin-3 on myocyte apoptosis and Ca(2+)-ATP enzyme levels following nerve injury in rats.

Authors:  Yu-Zhen Dong; Lin Yang; Tan Lu; Hong-Xing Zhao; Chao Ma; Yi-Lei Zhao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Transfection of neurotrophin-3 into neural stem cells using ultrasound with microbubbles to treat denervated muscle atrophy.

Authors:  Lin Gong; Changqing Jiang; Li Liu; Shengxiang Wan; Wen Tan; Sushuang Ma; Xiaojian Jia; Meiwei Wang; Azhen Hu; Yu Shi; Yu Zhang; Yuanyuan Shen; Feng Wang; Yun Chen
Journal:  Exp Ther Med       Date:  2017-11-06       Impact factor: 2.447

3.  Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial-mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4.

Authors:  Fengjie Hao; Xiaochun Fei; Xinping Ren; Joanna Xi Xiao; Yongjun Chen; Junqing Wang
Journal:  J Cell Mol Med       Date:  2020-09-13       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.